MGC Pharmaceuticals Ltd (ASX: MXC) Share Price and News

Price

 

Movement

   

  (20 mins delayed)

52 Week Range

  -  

 
1 Year Return

 

MGC Pharmaceuticals Ltd Chart and Price Data

Fundamentals Data provided by Morningstar.

Data provided by Morningstar.
Market Cap $17.98 million
P/E Ratio N/A
Dividend Yield 0.00%
Shares Outstanding 43.85 million
Earnings per share -3.206
Dividend per share N/A
Year To Date Return -11.58%
Earnings Yield N/A
Franking -
Share Price

Day Change

52 Week Range

-

Yesterday's Close

Today's Open

Days Range

-

Volume

Avg. Volume (1 month)

Turnover

as at 24 Feb 3:44pm

  • MGC Pharmaceuticals Ltd (ASX: MXC)
    Latest News

    a woman
    Share Gainers

    Why cannabis company MGC Pharmaceuticals surged 13% higher today

    The MGC Pharmaceuticals Ltd (ASX:MXC) share price surged 13% higher today after the cannabis company provided a positive update...

    Read more »

    a woman
    Share Gainers

    Why these ASX cannabis shares surged higher today

    The Botanix Pharmaceuticals Ltd (ASX:BOT) share price and the MGC Pharmaceuticals Ltd (ASX:MXC) share price have surged higher on Wednesday.…

    Read more »

    a woman
    Share Gainers

    Why these ASX cannabis shares are rocketing higher today

    The MGC Pharmaceuticals Ltd (ASX:MXC) share price and the THC Global Group Ltd (ASX:THC) share price are two of four…

    Read more »

    a woman
    Share Gainers

    Why cannabis company MGC Pharmaceuticals rocketed 38% higher today

    The MGC Pharmaceuticals Ltd (ASX:MXC) share price rocketed 38% higher on Wednesday. Here's why this cannabis company smoked the market...

    Read more »

    a woman
    Share Gainers

    MGC Pharma share price lifts on botanical update

    A botanical update from cannabis producer MGC Pharmaceuticals Ltd (ASX:MXC) has seen its share price respond favourably today as the company posted…

    Read more »

    a woman
    Share Gainers

    The AusCann share price is flying high and up 36% in a month

    The AusCann Group Holdings Ltd (ASX:AC8) share price is now up 36% in a month. Here's why it is on…

    Read more »

    a woman
    Share Gainers

    ASX cannabis shares have started the year on a high

    The Auscann Group Holdings Ltd (ASX:AC8) share price and the Creso Pharma Ltd (ASX:CPH) share price have started the year…

    Read more »

    a woman
    Share Gainers

    These small cap ASX shares are ending the week on a high

    The Amaysim Australia Ltd (ASX:AYS) share price is one of three at the small end of the market ending the…

    Read more »

    a woman
    Share Gainers

    Why these cannabis shares smoked the market on Tuesday

    Cannabis shares BOD Australia Ltd (ASX:BDA), Hydroponics Company Ltd (ASX:THC), and MGC Pharmaceuticals Ltd (ASX:MXC) smoked the market on Tuesday...

    Read more »

    a woman
    Share Market News

    These 3 ASX small cap shares have stormed higher on Thursday

    The Biotron Limited (ASX:BIT) share price is one of three storming higher at the small end of the market on…

    Read more »

    a woman
    Share Gainers

    Why MGC Pharmaceuticals Ltd (ASX:MXC) shares have rocketed 27% higher today

    Cannabis company MGC Pharmaceuticals Ltd (ASX:MXC) has outperformed the market today with a massive 27.5% push higher...

    Read more »

    a woman
    Share Market News

    Why these 3 ASX shares are in trading halts today

    ResApp Health Ltd (ASX:RAP) shares are one of three missing out on the market meltdown due to being in trading…

    Read more »

    MXC ASX Announcements

    An announcement is considered as "Price Sensitive" if it is thought that it may have an impact on the price of the security.

    DateAnnouncementPrice Sensitive?TimeNo. of PagesFile Size
    YesNo

    About MGC Pharmaceuticals Ltd

    MGC Pharmaceuticals Ltd is a biopharma company with a Nature to Medicine strategy at the forefront of the emerging phytocannabinoid and plant-derived medicine markets. The company's mission is to build an innovative, global bio-pharma company providing standardized, affordable plant-derived medicines of the highest regulatory compliance for targeted global markets.

    MXC Share Price History Data provided by Morningstar.

    Data provided by Morningstar.
    Date Close Change % Change Volume Open High Low
    28 Mar 2024 $0.41 $-0.01 -2.38% 9,618 $0.41 $0.41 $0.40
    27 Mar 2024 $0.42 $0.03 7.59% 13,088 $0.40 $0.42 $0.40
    26 Mar 2024 $0.40 $-0.02 -4.88% 38,947 $0.41 $0.41 $0.39
    25 Mar 2024 $0.41 $-0.03 -6.90% 1,435 $0.44 $0.44 $0.41
    22 Mar 2024 $0.44 $0.00 0.00% 2,710 $0.44 $0.44 $0.41
    21 Mar 2024 $0.44 $0.01 2.33% 25,204 $0.43 $0.44 $0.43
    20 Mar 2024 $0.43 $0.02 4.88% 11,514 $0.43 $0.43 $0.41
    19 Mar 2024 $0.41 $-0.01 -2.38% 43 $0.42 $0.42 $0.41
    18 Mar 2024 $0.42 $-0.02 -4.60% 1,040 $0.44 $0.44 $0.42
    15 Mar 2024 $0.44 $0.03 7.32% 5,114 $0.42 $0.44 $0.42
    14 Mar 2024 $0.41 $0.00 0.00% 10,067 $0.41 $0.43 $0.41
    13 Mar 2024 $0.41 $-0.01 -2.38% 86,359 $0.41 $0.42 $0.41
    12 Mar 2024 $0.42 $0.00 0.00% 102,188 $0.42 $0.42 $0.40
    11 Mar 2024 $0.42 $-0.01 -2.35% 17,054 $0.43 $0.43 $0.40
    08 Mar 2024 $0.43 $-0.01 -2.33% 65,674 $0.43 $0.43 $0.41
    07 Mar 2024 $0.43 $-0.02 -4.44% 6,201 $0.45 $0.45 $0.43
    06 Mar 2024 $0.45 $-0.05 -10.00% 86,357 $0.45 $0.45 $0.43
    05 Mar 2024 $0.50 $0.08 19.05% 133,054 $0.42 $0.50 $0.42
    04 Mar 2024 $0.42 $-0.03 -6.67% 36,052 $0.44 $0.50 $0.42
    01 Mar 2024 $0.45 $0.00 0.00% 60,235 $0.45 $0.45 $0.41
    29 Feb 2024 $0.45 $0.05 12.50% 13,116 $0.40 $0.45 $0.40
    28 Feb 2024 $0.40 $0.03 8.00% 19,552 $0.38 $0.40 $0.38
    27 Feb 2024 $0.38 $-0.04 -9.76% 16,733 $0.41 $0.41 $0.38

    Director Transactions Data provided by Morningstar.

    Data provided by Morningstar.
    Date Director Type Amount Value Notes
    05 May 2023 Brett Mitchell Expiry 17,500,000 $157,500
    As advised by the company. 49,00,000 Performance Rights, As per announcement on 05-05-2023
    05 May 2023 Ross Walker Expiry 1,050,000 $9,450
    As advised by the company. Lapse of Performance Rights
    05 May 2023 Nativ Segev Expiry 1,050,000 $9,450
    As advised by the company. 600,000 Performance Rights, AS per announcement on 05-05-2023
    05 May 2023 Roby Zomer Expiry 17,500,000 $157,500
    As advised by the company. 49,00,000 Performance Rights, As per announcement on 05-05-2023
    05 May 2023 Stephen Parker Expiry 1,400,000 $12,600
    As advised by the company. Lapse of Performance Rights, As per announcement on 05-05-2023

    Directors & Management Data provided by Morningstar.

    Data provided by Morningstar.
    Name Title Start Date Profile
    Mr Layton Patrick Mills Non-Executive Director Jun 2023
    Mr Mills is a life-sciences executive, having worked in the biotechnology and life sciences industries for over 15 years, developing experience across human and animal health in pharmaceutical and consumer healthcare.
    Mr Brett Anthony Mitchell Executive ChairmanExecutive Director Apr 2013
    Mr Mitchell has over 25 years of experience in the venture capital, equity capital markets, technology and resources sectors. He has been involved in the founding, financing and management of both private and publicly listed companies, and was instrumental in the successful LSE listing for MGC Pharma in February 2021.
    Mr Daniel Robinson Non-Executive Director Dec 2023
    Mr Robinson has 20 years experience in a range of corporate roles across stockbroking, corporate advisory, investor relations and governance. He is a Company Secretary and Director of both private and listed companies.
    Mr Nativ Segev Non-Executive Director Feb 2016
    Mr Segev has over 10 years of experience in implementation, legislation and lobbying in the global Medical Cannabis industry, combined with over 15 years of experience in diverse executive roles.
    Mr Roby Reuven Zomer Chief Executive OfficerManaging Director Feb 2016
    Mr Zomer was recruited into MGC Pharma by its founders at the inception of the company and has since served in multiple roles within the company, culminating with his current role as MD and CEO. With 11 years of experience in projects in the Biotech and Agrotech sectors, Mr Zomer has been necessary in moving MGC Pharma from a cannabis concept to a fully functioning biopharma company with global activities.
    Mr Messrs Rowan Harland Company Secretary Mar 2023
    -
    Messrs Rowan Harland Company Secretary
    -

    Top Shareholders Data provided by Morningstar.

    Data provided by Morningstar.
    Name Shares Capital
    Computershare Clearing Pty Ltd <Ccnl Di A/C> 1,416,661,256 31.99%
    Bioheka Limited 107,000,000 2.42%
    Citicorp Nominees Pty Limited 95,516,192 2.16%
    Orca Capital Gmbh 94,287,918 2.13%
    Hsbc Custody Nominees (Australia) Limited 93,845,701 2.12%
    BNP Paribas Nominees Pty Ltd Acf Clearstream 85,199,520 1.92%
    Mr Shachar Shimony 69,500,000 1.57%
    Mercer Street Global Opportunity Fund Llc 65,600,000 1.48%
    Sofia Even 51,000,000 1.15%
    Mr Michael Sean Newton 48,000,000 1.08%
    Chetcuti Holdings Pty Ltd 46,044,900 1.04%
    Mr George Bishay 36,822,890 0.83%
    Bnp Paribas Noms Pty Ltd <Drp> 36,108,923 0.82%
    Mrs Ilena Alemao 23,343,478 0.53%
    Mrs Yifat Steuer 17,193,146 0.39%
    Fairbrother Holdings Pty Ltd 16,043,478 0.36%
    Jep Pty Ltd <Jp Pension Fund A/C> 13,675,805 0.31%
    Ibi Trust Management <Nadya Lisovoder A/C> 13,372,365 0.31%
    Mr Gagandeep Singh 13,333,333 0.30%
    Mr Paul Merlo 13,043,488 0.29%

    Profile

    since

    Note